Background: To investigate the potential to predict prognosis of glioblastoma (GBM) patients by analysis of the broader and lower values in the lower distribution of apparent diffusion coefficient (ADC) (B&L-ADC) values in the ADC histogram.
Background: Presurgical publicly available diffusion-weighted images (DWI) and contrast-enhanced T1-weighted images from 76 GBM patients were analyzed. With applied 2-mixture normal distribution in the ADC histogram of enhanced lesions on T1-weighted images, the mean and width of ADC were analyzed. We dichotomized the lower mean of ADC (L-ADC) and the broader width of ADC (B-ADC) at their own average. B&L-ADC was defined as B-ADC with L-ADC. Progression-free survival (PFS) and overall survival (OS) were determined by using Cox proportional hazards analysis and the Kaplan-Meier method with the log-rank test. The difference between PFS and OS was calculated.
Results: Six (7.89%) patients had B&L-ADC values. B&L-ADC was strongly associated with poor PFS (hazard risk: 5.747; P=0.002) and OS (hazard risk: 3.331; P=0.018). There were significant differences in PFS (median, 77 vs. 302 days; P<0.001) and OS (median, 199 vs. 472 days; P=0.004) between the patents with and without B&L-ADC. There was no significant difference in the OS-PFS duration difference between the patients with (median, 79 days) and without B&L-ADC (median, 132 days) (P=0.348).
Conclusion: In this study, B&L-ADC from pretreatment ADC analysis predicted poor PFS. B&L-ADC may indicate higher cellularity and heterogeneity in GBM tumor tissue.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.neurad.2017.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary staging with 2[18F]-FDG-PET/CT and -PET/MRI and radiotherapy response evaluation with MRI in uterine cervical cancer: an interim analysis of a prospective clinical trial.
EJNMMI Rep
January 2025
Department of Diagnostics and Intervention, Diagnostic Radiology, Umeå University, Umeå, Sweden.
Background: In uterine cervical cancer (UCC), tumour staging is performed according to the 2018 International Federation of Gynecology and Obstetrics (FIGO) system, where imaging is incorporated, or the more generic Tumour Node Metastasis (TNM) classification. With the technical development in diagnostic imaging, continuous prospective evaluation of the different imaging methods contributing to stage determination is warranted. The aims of this interim study were to (1) evaluate the performance of radiological FIGO (rFIGO) and T staging (rT) with 2-fluorine-18-fluoro-deoxy-glucose (2[18F]-FDG)-positron emission tomography with computed tomography (PET/CT) and with magnetic resonance imaging (PET/MRI), compared to clinical FIGO (cFIGO) and T (cT) staging based on clinical examination and conventional imaging, in treatment-naïve UCC, and to (2) identify possible MRI biomarkers for early treatment response after radiotherapy.
View Article and Find Full Text PDFJoint k-b space diffusion-weighted image reconstruction and apparent diffusion coefficient fitting for diffusion-weighted turbo-spin-echo imaging.
Med Phys
January 2025
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Background: Diffusion-weighted (DW) turbo-spin-echo (TSE) imaging offers improved geometric fidelity compared to single-shot echo-planar-imaging (EPI). However, it suffers from low signal-to-noise ratio (SNR) and prolonged acquisition times, thereby restricting its applications in diagnosis and MRI-guided radiotherapy (MRgRT).
Purpose: To develop a joint k-b space reconstruction algorithm for concurrent reconstruction of DW-TSE images and the apparent diffusion coefficient (ADC) map with enhanced image quality and more accurate quantitative measurements.
Background: Diffusion MRI (dMRI) measures are variable across sites and MRI vendors, which leads to a site bias in the reported quantitative white matter metrics (Figure 1). ComBat is currently the go-to method for harmonizing MRI data. However, to our knowledge, the harmonization power of ComBat has not been convincingly demonstrated on the ADNI cohort and was never tested in the context of normative assessment for Alzheimer's disease (AD) patients.
View Article and Find Full Text PDFDeveloping Topics.
Alzheimers Dement
December 2024
School of Psychology, The University of Auckland, Auckland, New Zealand.
Background: Brain connectivity patterns, measured with Magnetic Resonance Imaging (MRI), have been recently studied as a potential biomarker for Alzheimer's disease dementia (AD). A 'disconnected brain' has been associated with greater cognitive impairment in pathological aging (Bennett & Madden, 2014), but it is unclear how this occurs in groups at risk of AD.
Method: Participants (n = 227; aged 55+ years) from the Dementia Prevention Research Clinic, New Zealand, were classified as control (C; n = 35), subjective cognitive decline (SCD; n = 60), single-domain amnestic mild cognitive impairment (aMCI; n = 54), multiple-domain MCI (mMCI; n = 52), and AD (n = 26).
Developing Topics.
Alzheimers Dement
December 2024
Multiscale Imaging and Integrative Biophysics Unit, National Institute on Aging, NIH,, Baltimore, MD, USA.
Background: Cognitive impairment with age remains undetected until it interferes daily life activity or presents dementia symptoms. In the US, 61% of dementia population is not diagnosed, which is in part due to limited sensitivity of clinical neuroimaging modalities in assessing early gray matter (GM) changes. Here we look at microstructural changes in GM using mean apparent propagator (MAP-MRI) in cognitively underperforming (CU) and healthy aging (HA) cohorts, grouped according to their cognitive performance based on the NIH Toolbox.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!